These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 2481707)
1. Improved estimates of clearance of 131I-labelled insulin-like growth factor-I carrier protein complexes from blood plasma of sheep. Davis SR; Hodgkinson SC; Moore LG; Gluckman PD J Endocrinol; 1989 Dec; 123(3):469-75. PubMed ID: 2481707 [TBL] [Abstract][Full Text] [Related]
2. Metabolic clearance of insulin-like growth factor-II in sheep. Hodgkinson SC; Davis SR; Moore LG; Henderson HV; Gluckman PD J Endocrinol; 1989 Dec; 123(3):461-8. PubMed ID: 2607256 [TBL] [Abstract][Full Text] [Related]
3. Plasma clearance of chicken and human insulin-like growth factor-I and their association with circulating binding proteins in chickens. Francis GL; McMurtry JP; Johnson RJ; Ballard FJ J Endocrinol; 1990 Mar; 124(3):361-70. PubMed ID: 2332715 [TBL] [Abstract][Full Text] [Related]
4. Metabolic clearance rate of insulin-like growth factor-I in fed and starved sheep. Hodgkinson SC; Davis SR; Burleigh BD; Henderson HV; Gluckman PD J Endocrinol; 1987 Nov; 115(2):233-40. PubMed ID: 3437248 [TBL] [Abstract][Full Text] [Related]
5. Plasma clearance and tissue distribution of labelled chicken and human IGF-I and IGF-II in the chicken. McMurtry JP; Francis GL; Upton Z; Walton PE; Rosselot G; Caperna TJ; Brocht DM J Endocrinol; 1996 Jul; 150(1):149-60. PubMed ID: 8708556 [TBL] [Abstract][Full Text] [Related]
6. Characterization of insulin-like growth factor binding proteins in ovine tissue fluids. Hodgkinson SC; Moore L; Napier JR; Davis SR; Bass JJ; Gluckman PD J Endocrinol; 1989 Mar; 120(3):429-38. PubMed ID: 2466934 [TBL] [Abstract][Full Text] [Related]
7. Plasma clearance and tissue distribution of labelled insulin-like growth factor-I (IGF-I) and an analogue LR3IGF-I in pregnant rats. Bastian SE; Walton PE; Wallace JC; Ballard FJ J Endocrinol; 1993 Aug; 138(2):327-36. PubMed ID: 7693845 [TBL] [Abstract][Full Text] [Related]
8. Transfer of insulin-like growth factor (IGF)-I from blood to intestine: comparison with IGFs that bind poorly to IGF-binding proteins. Lord AP; Martin AA; Ballard FJ; Read LC J Endocrinol; 1994 Jun; 141(3):505-15. PubMed ID: 7520931 [TBL] [Abstract][Full Text] [Related]
9. Elimination of radiolabelled recombinant human insulin-like growth factor binding protein-3 from the circulation, and its distribution amongst organs and tissues in adult male rats. Arany E; Zabel P; Freeman D; Hill DJ Regul Pept; 1993 Oct; 48(1-2):133-43. PubMed ID: 7505460 [TBL] [Abstract][Full Text] [Related]
10. Influence of insulin-like growth factor-binding protein-2 on plasma clearance and transfer of insulin-like growth factors-I and -II from plasma into mammary-derived lymph and milk of goats. Prosser CG; Schwander J J Endocrinol; 1996 Jul; 150(1):121-7. PubMed ID: 8708553 [TBL] [Abstract][Full Text] [Related]
11. Characterization of insulin-like growth factor-binding protein in ovine amniotic fluid. Wang JF; Fraher LJ; Hill DJ J Endocrinol; 1990 Nov; 127(2):325-33. PubMed ID: 1701191 [TBL] [Abstract][Full Text] [Related]
12. Plasma clearance and tissue distribution of labelled insulin-like growth factor-I (IGF-I), IGF-II and des(1-3)IGF-I in rats. Ballard FJ; Knowles SE; Walton PE; Edson K; Owens PC; Mohler MA; Ferraiolo BL J Endocrinol; 1991 Feb; 128(2):197-204. PubMed ID: 2005410 [TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factor-binding proteins in tissue fluids from the lamb. Lord AP; Martin AA; Walton PE; Ballard FJ; Read LC J Endocrinol; 1991 Apr; 129(1):59-68. PubMed ID: 1709420 [TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates. Guler HP; Zapf J; Schmid C; Froesch ER Acta Endocrinol (Copenh); 1989 Dec; 121(6):753-8. PubMed ID: 2558477 [TBL] [Abstract][Full Text] [Related]
16. Rapid clearance of insulin-like growth factor (IGF)-binding protein species from blood and an associated fall in circulating IGF-I following partial hepatectomy in the rat. Phillips ID; Arany E; Strain AJ; Han VK; Hill DJ J Endocrinol; 1993 May; 137(2):271-80. PubMed ID: 7686958 [TBL] [Abstract][Full Text] [Related]
17. Serum half-life and biological activity of mutants of human insulin-like growth factor I which do not bind to serum binding proteins. Cascieri MA; Saperstein R; Hayes NS; Green BG; Chicchi GG; Applebaum J; Bayne ML Endocrinology; 1988 Jul; 123(1):373-81. PubMed ID: 2454805 [TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor (IGF) binding protein from human decidua inhibits the binding and biological action of IGF-I in cultured choriocarcinoma cells. Ritvos O; Ranta T; Jalkanen J; Suikkari AM; Voutilainen R; Bohn H; Rutanen EM Endocrinology; 1988 May; 122(5):2150-7. PubMed ID: 2452077 [TBL] [Abstract][Full Text] [Related]
19. Failure of acid-ethanol treatment to prevent interference by binding proteins in radioligand assays for the insulin-like growth factors. Mesiano S; Young IR; Browne CA; Thorburn GD J Endocrinol; 1988 Dec; 119(3):453-60. PubMed ID: 2464662 [TBL] [Abstract][Full Text] [Related]
20. Properties of glycosylated and non-glycosylated human recombinant IGF binding protein-3 (IGFBP-3). Sommer A; Spratt SK; Tatsuno GP; Tressel T; Lee R; Maack CA Growth Regul; 1993 Mar; 3(1):46-9. PubMed ID: 7683528 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]